JP Stock MarketDetailed Quotes

4565 Nxera Pharma

Watchlist

1680
+25+1.51%

20min DelayMarket Closed Jul 12 15:00 JST

151.04BMarket Cap-19270P/E (Static)

Nxera Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

388.97%4.61B

-18.00%12.77B

5.25%7.29B

-46.18%3.33B

-10.09%1.2B

-15.73%943M

-12.10%15.57B

-50.94%6.93B

1,224.20%6.18B

-30.17%1.34B

Cost of revenue

1,194.57%1.19B

234.99%3.1B

840.86%1.75B

439.23%1.13B

-45.27%133M

-68.06%92M

-0.75%926M

-36.95%186M

9.42%209M

9.95%243M

Gross profit

301.88%3.42B

-34.00%9.66B

-17.80%5.54B

-63.16%2.2B

-2.28%1.07B

2.41%851M

-12.73%14.64B

-51.24%6.74B

2,064.86%5.98B

-35.40%1.1B

Operating expense

130.76%6.5B

71.23%19.19B

162.95%7.08B

116.26%6.03B

21.57%3.27B

-7.31%2.82B

-13.82%11.21B

-53.82%2.69B

5.05%2.79B

16.78%2.69B

Selling and administrative expenses

229.13%3.65B

127.67%9.97B

227.51%3.95B

280.22%3.44B

60.48%1.46B

-18.09%1.11B

11.09%4.38B

14.73%1.21B

-5.14%905M

-5.01%911M

-General and administrative expense

229.13%3.65B

127.67%9.97B

227.51%3.95B

280.22%3.44B

60.48%1.46B

-18.09%1.11B

11.09%4.38B

14.73%1.21B

-5.14%905M

-5.01%911M

Research and development costs

61.62%3.16B

35.16%10.08B

67.23%3.06B

54.49%2.97B

9.93%2.08B

8.48%1.96B

25.68%7.45B

14.51%1.83B

11.01%1.93B

36.16%1.89B

Other operating expenses

--2M

4,600.00%94M

6,000.00%61M

--2M

500.00%30M

----

-99.94%2M

-99.97%1M

----

--5M

Total other operating income

27.09%319M

50.80%944M

--0

790.91%392M

156.41%300M

107.44%251M

7,725.00%626M

416.36%348M

18.92%44M

165.91%117M

Operating profit

-56.62%-3.08B

-377.24%-9.53B

-137.87%-1.53B

-219.91%-3.82B

-37.92%-2.2B

10.97%-1.96B

-8.98%3.44B

-49.36%4.05B

234.22%3.19B

-161.54%-1.6B

Net non-operating interest income (expenses)

177.23%280M

-1,140.86%-1.15B

-531.03%-1.28B

-330.33%-281M

420.34%307M

242.25%101M

97.42%-93M

93.94%-203M

156.22%122M

160.20%59M

Non-operating interest income

70.33%465M

102.26%1.34B

1,146.43%349M

25.86%365M

117.75%503M

131.36%273M

233.17%663M

110.04%28M

-4.92%290M

11,450.00%231M

Non-operating interest expense

7.56%185M

230.03%2.5B

605.63%1.63B

284.52%646M

13.95%196M

-8.99%172M

-80.09%756M

-92.48%231M

-67.82%168M

72.00%172M

Net investment income

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

Income from associates and other participating interests

-958.00%-429M

612.12%338M

-81.33%-301M

-166.49%-246M

Special income (charges)

-991.26%-1.84B

-1.84B

Less:Write off

----

--0

----

991.26%1.84B

--0

--1.84B

----

Other non-operating income (expenses)

Income before tax

-50.08%-2.8B

-1,090.72%-10.68B

-167.25%-2.82B

-449.66%-4.11B

-6.27%-1.9B

25.39%-1.86B

148.96%1.08B

-8.70%4.19B

142.55%1.17B

-426.55%-1.79B

Income tax

205.21%485M

-601.01%-3.49B

-550.26%-2.61B

-4.76%820M

-290.85%-1.24B

-7.96%-461M

219.18%696M

-66.78%579M

126.65%861M

-139.38%-317M

Net income

-134.02%-3.28B

-1,982.98%-7.19B

-105.77%-208M

-1,673.48%-4.93B

55.18%-658M

32.27%-1.4B

-62.44%382M

26.92%3.61B

-33.69%313M

-28.32%-1.47B

Net income continuous operations

-134.02%-3.28B

-1,982.98%-7.19B

-105.77%-208M

-1,673.48%-4.93B

55.18%-658M

32.27%-1.4B

-62.44%382M

26.92%3.61B

-33.69%313M

-28.32%-1.47B

Noncontrolling interests

Net income attributable to the company

-134.02%-3.28B

-1,982.98%-7.19B

-105.77%-208M

-1,673.48%-4.93B

55.18%-658M

32.27%-1.4B

-62.44%382M

26.92%3.61B

-33.69%313M

-28.32%-1.47B

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-134.02%-3.28B

-1,982.98%-7.19B

-105.77%-208M

-1,673.48%-4.93B

55.18%-658M

32.27%-1.4B

-62.44%382M

26.92%3.61B

-33.69%313M

-28.32%-1.47B

Gross dividend payment

Basic earnings per share

-114.38%-36.68

-1,962.82%-87.18

-104.83%-2.13

-1,665.71%-59.81

55.29%-8.03

32.61%-17.11

-62.65%4.68

26.01%44.14

-34.14%3.82

-27.38%-17.96

Diluted earnings per share

-114.38%-36.68

-1,982.94%-87.18

-104.83%-2.13

-1,682.28%-59.81

55.29%-8.03

32.61%-17.11

-62.66%4.63

26.33%44.09

-34.26%3.78

-27.38%-17.96

Dividend per share

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	388.97%4.61B	-18.00%12.77B	5.25%7.29B	-46.18%3.33B	-10.09%1.2B	-15.73%943M	-12.10%15.57B	-50.94%6.93B	1,224.20%6.18B	-30.17%1.34B
Cost of revenue	1,194.57%1.19B	234.99%3.1B	840.86%1.75B	439.23%1.13B	-45.27%133M	-68.06%92M	-0.75%926M	-36.95%186M	9.42%209M	9.95%243M
Gross profit	301.88%3.42B	-34.00%9.66B	-17.80%5.54B	-63.16%2.2B	-2.28%1.07B	2.41%851M	-12.73%14.64B	-51.24%6.74B	2,064.86%5.98B	-35.40%1.1B
Operating expense	130.76%6.5B	71.23%19.19B	162.95%7.08B	116.26%6.03B	21.57%3.27B	-7.31%2.82B	-13.82%11.21B	-53.82%2.69B	5.05%2.79B	16.78%2.69B
Selling and administrative expenses	229.13%3.65B	127.67%9.97B	227.51%3.95B	280.22%3.44B	60.48%1.46B	-18.09%1.11B	11.09%4.38B	14.73%1.21B	-5.14%905M	-5.01%911M
-General and administrative expense	229.13%3.65B	127.67%9.97B	227.51%3.95B	280.22%3.44B	60.48%1.46B	-18.09%1.11B	11.09%4.38B	14.73%1.21B	-5.14%905M	-5.01%911M
Research and development costs	61.62%3.16B	35.16%10.08B	67.23%3.06B	54.49%2.97B	9.93%2.08B	8.48%1.96B	25.68%7.45B	14.51%1.83B	11.01%1.93B	36.16%1.89B
Other operating expenses	--2M	4,600.00%94M	6,000.00%61M	--2M	500.00%30M	----	-99.94%2M	-99.97%1M	----	--5M
Total other operating income	27.09%319M	50.80%944M	--0	790.91%392M	156.41%300M	107.44%251M	7,725.00%626M	416.36%348M	18.92%44M	165.91%117M
Operating profit	-56.62%-3.08B	-377.24%-9.53B	-137.87%-1.53B	-219.91%-3.82B	-37.92%-2.2B	10.97%-1.96B	-8.98%3.44B	-49.36%4.05B	234.22%3.19B	-161.54%-1.6B
Net non-operating interest income (expenses)	177.23%280M	-1,140.86%-1.15B	-531.03%-1.28B	-330.33%-281M	420.34%307M	242.25%101M	97.42%-93M	93.94%-203M	156.22%122M	160.20%59M
Non-operating interest income	70.33%465M	102.26%1.34B	1,146.43%349M	25.86%365M	117.75%503M	131.36%273M	233.17%663M	110.04%28M	-4.92%290M	11,450.00%231M
Non-operating interest expense	7.56%185M	230.03%2.5B	605.63%1.63B	284.52%646M	13.95%196M	-8.99%172M	-80.09%756M	-92.48%231M	-67.82%168M	72.00%172M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests		0			0		-958.00%-429M	612.12%338M	-81.33%-301M	-166.49%-246M
Special income (charges)		0					-991.26%-1.84B	0	-1.84B
Less:Write off	----	--0	----	----	----	----	991.26%1.84B	--0	--1.84B	----
Other non-operating income (expenses)
Income before tax	-50.08%-2.8B	-1,090.72%-10.68B	-167.25%-2.82B	-449.66%-4.11B	-6.27%-1.9B	25.39%-1.86B	148.96%1.08B	-8.70%4.19B	142.55%1.17B	-426.55%-1.79B
Income tax	205.21%485M	-601.01%-3.49B	-550.26%-2.61B	-4.76%820M	-290.85%-1.24B	-7.96%-461M	219.18%696M	-66.78%579M	126.65%861M	-139.38%-317M
Net income	-134.02%-3.28B	-1,982.98%-7.19B	-105.77%-208M	-1,673.48%-4.93B	55.18%-658M	32.27%-1.4B	-62.44%382M	26.92%3.61B	-33.69%313M	-28.32%-1.47B
Net income continuous operations	-134.02%-3.28B	-1,982.98%-7.19B	-105.77%-208M	-1,673.48%-4.93B	55.18%-658M	32.27%-1.4B	-62.44%382M	26.92%3.61B	-33.69%313M	-28.32%-1.47B
Noncontrolling interests
Net income attributable to the company	-134.02%-3.28B	-1,982.98%-7.19B	-105.77%-208M	-1,673.48%-4.93B	55.18%-658M	32.27%-1.4B	-62.44%382M	26.92%3.61B	-33.69%313M	-28.32%-1.47B
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	-134.02%-3.28B	-1,982.98%-7.19B	-105.77%-208M	-1,673.48%-4.93B	55.18%-658M	32.27%-1.4B	-62.44%382M	26.92%3.61B	-33.69%313M	-28.32%-1.47B
Gross dividend payment
Basic earnings per share	-114.38%-36.68	-1,962.82%-87.18	-104.83%-2.13	-1,665.71%-59.81	55.29%-8.03	32.61%-17.11	-62.65%4.68	26.01%44.14	-34.14%3.82	-27.38%-17.96
Diluted earnings per share	-114.38%-36.68	-1,982.94%-87.18	-104.83%-2.13	-1,682.28%-59.81	55.29%-8.03	32.61%-17.11	-62.66%4.63	26.33%44.09	-34.26%3.78	-27.38%-17.96
Dividend per share
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall